Merck & Co., Inc. (NYSE:MRK) April 28, 2015

Stock Price
View Comparative Chart →
Full Screen
1D
Chart
Select Tool
  • O:
  • H:
  • V:
  • C:
  • L:
savecancel
(right-click to delete)
--
MRK-US
Implied Price
UNDERVALUED
52.49 65.93
A Price as of Close Apr 27 57.10 USD
B CapitalCube Median Implied Price 64.10 USD * CapitalCube Price is over trading range * CapitalCube Price is below trading range
CapitalCube Estimate Range 62.28 - 65.93 USD NA
52 Week Range 52.49 - 63.62 USD
Earnings Momentum Score
 0  100
A Earnings Score (MRK) 51.84
B Earnings Score(Peer Median) 37.32
Latest Filing date December 31, 2014
Fundamental Score
 0  100
A Fundamental Score (MRK) 59
B Fundamental Score(Peer Median) 53
Dividend Score
 0  100
A Dividend Quality Score (MRK) 58
B Dividend Quality Score (Peer Median) 58
Dividend Yield
1.87 5.54
A Dividend Yield (MRK) 3.12
B Dividend Yield (Peer Median) 2.78
Analysis
Unlock The Complete Analysis →

Fundamental Analysis

Capital Investment Strategy unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Earnings Leverage unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Leverage & Liquidity unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Relative Valuation unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Valuation Drivers unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Drivers of Margin unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Growth Expectations unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Operations Diagnostic unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Sustainability of Returns unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Likely Corporate Actions

Dividend Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Equity Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

M&A Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality

Dividend Coverage unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality Trend unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Accounting Red Flags

Accounting Quality unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Management of Reserves unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Material Categories unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate
Price History

Peers

FA Score

DQ Score

close

52 week range

57.10

52.49

63.62

USD

34.59

27.51

35.53

USD

100.58

95.10

109.49

USD

70.89

57.81

77.46

USD

52.28

43.57

57.42

USD

290.41

257.20

320.50

USD

103.91

84.17

105.82

USD

47.49

37.78

48.62

USD

Company Profile

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company operates through the following segments: Pharmaceutical, Animal Health and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Its vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The company was founded in 1851 and is headquartered in Kenilworth, NJ.

Closing Stock Price

USD 57.1

As of Date

April 27, 2015

One Year Performance

-0.24%

One Month Performance

-1.13%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 161,504.67

Total Shares Outstanding

2838.140196
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

December 31, 2014

Next Release Date

April 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Peers


Latest Tweets via StockTwits
MRK
Please login to stocktwits
Post your response
share chart (wait for to display dialog to show)
Message must be no longer than 140 characters.
21
share page
SwingTradeBot
2m
Scan results - Crossed Above 50 DMA today: $RCII $OMI $IRM $FLWS $MRK $MAS $APD $ALLY $UPS $WAT ... http://stks.co/e27wK
Apr 28 9:31 PM
Unbiasedtrading
16m
Hepatitis C Competitive Landscape: The Holy Grail http://stks.co/q1wF7 $ABBV $ACHN $BMY $ENTA $GILD $JNJ $MRK $RGLS
Apr 28 9:16 PM
361 Capital
1h
$SPX +0.3%. A mixed earnings day with $MRK rewarding and $AAPL being ignored. ConsConf & Richmond Fed wte. Bonds & US$ very weak.
Apr 28 8:28 PM
TheStreet
1h
Stocks Finish Mixed in Eventful Day for Markets $MRK http://stks.co/p1w80
Apr 28 8:15 PM
CBOE
2h
Active options @ CBOE: $AAPL $TSLA $TWTR $YPF $AMZN $X $PBR $MRK $JBLU $ABX
Apr 28 8:0 PM
Confident Investor
2h
Today, I increased my investment in $MRK $MEI $YUM $EQIX $NFLX . I think these #stocks have the potential to grow more.
Apr 28 8:0 PM
hoonster soon
2h
$MRK I'm looking at $63.50.... gonna be there very soon. Another big move next couple days.
Apr 28 7:53 PM
George
2h
$MRK ..day high scalp?
Apr 28 7:42 PM
Groucho Marx
2h
$ENZN $MRK " Merck added 5.5 percent after the drugmaker lifted its annual earnings forecast" one of few up today..
Apr 28 7:28 PM
Marc Munoz
2h
$MRK 1Q15 GAAP EPS $0.33 vs EPS $0.57 1Q14, lowers 2015 Full-Year GAAP EPS Target from $1.85 to $1.58, Net income 1Q15 $1,473M vs $896M 1Q14
Apr 28 7:5 PM
James Sweeney
3h
Wall Street #MarketMovers 4/28 Apple volatile $AAPL Merck up on earnings $MRK $BP beats the Street, Pfizer dives $PFE http://stks.co/e27qI
Apr 28 6:50 PM
Bidness Etc
3h
Merck & Co Diabetes Drug Januvia Reveals Positive Results In Heart Safety Trial http://stks.co/r1vx7 $MRK
Apr 28 6:28 PM
Yamasuta.com
3h
$MRK Signal still SHORT at 57.1 - by Yamasuta.com - Free Algorithmic Software - Free Until Jan 1st, 2016
Apr 28 6:9 PM
Joshua Rodriguez
4h
Get ready for more big gains $MRK bulls http://stks.co/f2CpN
Apr 28 5:15 PM
Hanie Suber
4h
Merck & Co Diabetes Drug Januvia Reveals Positive Results In Heart Safety Trial $MRK http://stks.co/c27gX
Apr 28 5:11 PM
Briefingcom
5h
Apr 28 5:1 PM
Peter
5h
ICYMI: Organovo $ONVO & Merck $MRK Enter Multi-year Research Partnership for 3D Printed Human Tissue http://stks.co/f2CoJ
Apr 28 4:36 PM
2
Van Eck Global
5h
$MOAT holding $MRK boosts 2015 annual profit forecast given strong 1Q results http://stks.co/g2CZb $MOAT holdings: http://stks.co/f2CoC
Apr 28 4:33 PM
TheStreet
5h
Stocks Hold Onto Slight Gains as Merck Leads Dow $MRK http://stks.co/e27lR
Apr 28 4:10 PM
TerriG
6h
$ADRO 13G from $NVS Novartis = 5.21% stake http://stks.co/i2Cqb … #immunotherapy #stocks $LCINDX #AACR15 $ADXS $NVS $MRK $JNJ $IBB $XBI
Apr 28 4:3 PM
1
Unbiasedtrading
6h
Merck hurdles Wall Street forecasts - Yahoo Finance http://stks.co/s1viC $MRK $$GILD
Apr 28 3:44 PM
Conference Call Transcripts
6h
Reading comments stated on the $MRK transcript http://stks.co/g2CXi
Apr 28 3:41 PM
d0ke
6h
Just enteret that $MRK trade. Live position management via @TickerTV here ticker.tv/d0ke
Apr 28 3:39 PM
Jason
6h
$FB Focus on Long Run Returns And To Keep Free Services To Drive User Number Growth- $OLN $MRK http://stks.co/a27iF
Apr 28 3:30 PM
Bob
6h
$MRK nice! Let her run a little more and take profits.
Apr 28 3:29 PM
Slim Cognito
6h
$MRK My October calls are up 59.375% since I bought them on the 21st....tempted to hold but the profits are just staring at my face
Apr 28 3:27 PM
TheStreet
6h
Merck (MRK) Earnings Report: Q1 2015 Conference Call Transcript $MRK http://stks.co/h2D4L
Apr 28 3:20 PM
Investing.com
6h
Merck & Co, $MRK , is up 5% - http://stks.co/e27jH
Apr 28 3:10 PM
Christy Ai
7h
@Sanctuary high volatility morning- trying to balance out risk mgmt and capturing profit from these swings. $MRK good readthru for the space
Apr 28 2:59 PM
1
Christy Ai
7h
$ACT seriously nice reversal here. Times like these were quality of the company restores confidence and leads the sector $MRK $SHPG $VRX
Apr 28 2:50 PM
1
Please Login to see your stream! No Twits! Your stream is empty No Twits for MRK!

Closing Stock Price

USD 57.1

As of Date

April 27, 2015

One Year Performance

-0.24%

One Month Performance

-1.13%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 161,504.666

Total Shares Outstanding (Millions)

2,838.14
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

December 31, 2014

Next Release Date

April 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Register
to customize peers
Peer analysis →